FYI, Frank Poullas is not the CEO It definitely inspires confidence because he could be putting his money into basically any investment under super. He obviously sees Magnis as the best opportunity for gains.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025